<p>添加</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>将其添加为您在 Google 上的首选新闻来源</p>
<p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>立即添加</p>
<p>周五，几家生物科技和医疗保健公司在盘后交易中表现出显著涨幅，投资者对与药物开发、医疗服务和融资更新相关的公司表现出 renewed interest。</p>
<p>Zentalis Pharmaceuticals, Inc. (ZNTL) 领涨，涨幅达到 17.65%，收于 4.40 美元，盘后上涨 0.66 美元。尽管周五没有新的消息，但该公司最近在 2026 年 1 月 6 日提供了一份企业更新，强调了关键里程碑和预计在其 azenosertib 开发项目中的动力。这一更新似乎增强了投资者对公司管道进展的信心。</p>
<p>LifeMD, Inc. (LFMD) 也实现了强劲的涨幅，攀升 12.18% 至 4.33 美元，上涨 0.47 美元。这一变动发生在 LifeMD 宣布与 Citizens Bank, N.A.完成一项新的高级担保循环信贷设施的几天后。该设施提供高达 5000 万美元的总可用额度，其中 3000 万美元已承诺，另外 2000 万美元为可选择的额度。管理层强调在关闭时没有提取余额，称手头现金充足，预计现金流能够支持有机增长计划。</p>
<p>NanoViricides, Inc. (NNVC) 上涨 11.11%，盘后收于 1.24 美元，涨幅为 0.12 美元。该公司周五没有发布新闻，但该股在交易结束时吸引了投机兴趣。</p>
<p>Intelligent Bio Solutions Inc. (INBS) 涨幅为 9.10%，收于 19.55 美元，上涨 1.63 美元。尽管没有新的公告，该股仍然受到投资者对生物科技行业的热情推动。</p>
<p>IO Biotech, Inc. (IOBT) 上涨 6.49%，至 0.60 美元，盘后上涨 0.037 美元。该公司周五没有新闻，但这一变动表明在较低价格水平上存在抄底活动。</p>
<p>Neurogene Inc. (NGNE) 上涨 2.06%，收于 18.29 美元，上涨 0.37 美元。本周早些时候，Neurogene 宣布其管理团队将参加第 44 届年度摩根大通医疗保健会议，届时他们将介绍公司概况并与投资者会面。</p>
<p>China SXT Pharmaceuticals, Inc. (SXTC) 也上涨 2.06%，至 18.29 美元，上涨 0.37 美元。该公司最近披露与单一投资者达成了一项最终协议，购买 66666666 股 A 类普通股（或预先融资的认股权证），每股价格为 0.15 美元，属于注册直接发行。这一融资举措突显了其加强资本状况的持续努力。</p>
<p>如需评论和反馈，请联系：editorial@rttnews.com</p>
<p>商业新闻</p>

LFMD

ZNTL

NNVC

<p>几家生物科技和医疗保健公司在盘后交易中实现了显著涨幅，其中 Zentalis Pharmaceuticals 上涨了 17.65%，至 4.40 美元。LifeMD 在宣布新的信贷融资后上涨了 12.18%，而 NanoViricides 上涨了 11.11%。其他值得注意的涨幅公司包括 Intelligent Bio Solutions、IO Biotech 和 Neurogene，后者参与了摩根大通医疗保健会议。中国 SXT Pharmaceuticals 在达成融资协议以增强其资本实力后也有所上涨。总体来看，投资者对药物开发和医疗服务的兴趣似乎正在上升</p>

<p>Add</p>
<div class="lb-trans"><p>添加</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png" alt="" original-src="https://cdn.rttnews.com/images/v4/RTTNews-Logo-224x61.png"/></p>
<p>as your preferred news source on Google</p>
<div class="lb-trans"><p>将其添加为您在 Google 上的首选新闻来源</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://cdn.rttnews.com/images/v4/google.png" alt="" original-src="https://cdn.rttnews.com/images/v4/google.png"/></p>
<p>Add Now</p>
<div class="lb-trans"><p>立即添加</p>
</div><p>Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates.</p>
<div class="lb-trans"><p>周五，几家生物科技和医疗保健公司在盘后交易中表现出显著涨幅，投资者对与药物开发、医疗服务和融资更新相关的公司表现出 renewed interest。</p>
</div><p>Zentalis Pharmaceuticals, Inc. (ZNTL) led the pack, surging 17.65% to close at $4.40, up $0.66 in the after-hours session. While there was no fresh news on Friday, the company recently provided a corporate update on January 6, 2026, highlighting key milestones and expected momentum in its azenosertib development program for the year. The update appears to have bolstered investor confidence in the company's pipeline progress.</p>
<div class="lb-trans"><p>Zentalis Pharmaceuticals, Inc. (ZNTL) 领涨，涨幅达到 17.65%，收于 4.40 美元，盘后上涨 0.66 美元。尽管周五没有新的消息，但该公司最近在 2026 年 1 月 6 日提供了一份企业更新，强调了关键里程碑和预计在其 azenosertib 开发项目中的动力。这一更新似乎增强了投资者对公司管道进展的信心。</p>
</div><p>LifeMD, Inc. (LFMD) also saw strong gains, climbing 12.18% to $4.33, up $0.47. The move comes days after LifeMD announced the closing of a new senior secured revolving credit facility with Citizens Bank, N.A. The facility provides up to $50 million in total availability, with $30 million committed and an additional $20 million accordion option. Management emphasized that no balance was drawn at closing, citing sufficient cash on hand and expected cash flow to fund organic growth initiatives.</p>
<div class="lb-trans"><p>LifeMD, Inc. (LFMD) 也实现了强劲的涨幅，攀升 12.18% 至 4.33 美元，上涨 0.47 美元。这一变动发生在 LifeMD 宣布与 Citizens Bank, N.A.完成一项新的高级担保循环信贷设施的几天后。该设施提供高达 5000 万美元的总可用额度，其中 3000 万美元已承诺，另外 2000 万美元为可选择的额度。管理层强调在关闭时没有提取余额，称手头现金充足，预计现金流能够支持有机增长计划。</p>
</div><p>NanoViricides, Inc. (NNVC) advanced 11.11%, finishing at $1.24 after-hours, a gain of $0.12. The company did not release news on Friday, but the stock attracted speculative interest late in the session.</p>
<div class="lb-trans"><p>NanoViricides, Inc. (NNVC) 上涨 11.11%，盘后收于 1.24 美元，涨幅为 0.12 美元。该公司周五没有发布新闻，但该股在交易结束时吸引了投机兴趣。</p>
</div><p>Intelligent Bio Solutions Inc. (INBS) posted a 9.10% jump, closing at $19.55, up $1.63. Despite no new announcements, the stock continued to draw momentum from investor enthusiasm in the biotech sector.</p>
<div class="lb-trans"><p>Intelligent Bio Solutions Inc. (INBS) 涨幅为 9.10%，收于 19.55 美元，上涨 1.63 美元。尽管没有新的公告，该股仍然受到投资者对生物科技行业的热情推动。</p>
</div><p>IO Biotech, Inc. (IOBT) rose 6.49% to $0.60, adding $0.037 in after-hours trading. The company had no news on Friday, but the move suggests bargain-hunting activity at lower price levels.</p>
<div class="lb-trans"><p>IO Biotech, Inc. (IOBT) 上涨 6.49%，至 0.60 美元，盘后上涨 0.037 美元。该公司周五没有新闻，但这一变动表明在较低价格水平上存在抄底活动。</p>
</div><p>Neurogene Inc. (NGNE) gained 2.06%, closing at $18.29, up $0.37. Earlier in the week, Neurogene announced that its management team will participate in the 44th Annual J.P. Morgan Healthcare Conference, where they will present a company overview and meet with investors.</p>
<div class="lb-trans"><p>Neurogene Inc. (NGNE) 上涨 2.06%，收于 18.29 美元，上涨 0.37 美元。本周早些时候，Neurogene 宣布其管理团队将参加第 44 届年度摩根大通医疗保健会议，届时他们将介绍公司概况并与投资者会面。</p>
</div><p>China SXT Pharmaceuticals, Inc. (SXTC) also advanced 2.06% to $18.29, up $0.37. The company recently disclosed a definitive agreement with a single investor for the purchase of 66,666,666 Class A ordinary shares (or pre-funded warrants) at $0.15 per share in a registered direct offering. The financing move highlights ongoing efforts to strengthen its capital position.</p>
<div class="lb-trans"><p>China SXT Pharmaceuticals, Inc. (SXTC) 也上涨 2.06%，至 18.29 美元，上涨 0.37 美元。该公司最近披露与单一投资者达成了一项最终协议，购买 66666666 股 A 类普通股（或预先融资的认股权证），每股价格为 0.15 美元，属于注册直接发行。这一融资举措突显了其加强资本状况的持续努力。</p>
</div><p>For comments and feedback contact: editorial@rttnews.com</p>
<div class="lb-trans"><p>如需评论和反馈，请联系：editorial@rttnews.com</p>
</div><p>Business News</p>
<div class="lb-trans"><p>商业新闻</p>
</div>

盘后股价上涨：ZeZentalis Pharma、LifeMD 和 Nanoviricides 是涨幅最大的股票之一